STEVIE-MARIE MULLINS: Open Payments
NPI 1760192868 · CENTERVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,331 in 44 payments from 9 companies in 2025. Trend: 2023 $1,194 · 2024 $235 · 2025 $2,331
Food & beverage: $1,359Consulting: $900Education: $72
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 25 | $1,321 |
| Janssen Biotech, Inc. | 5 | $483 |
| UCB, Inc. | 3 | $230 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Organon LLC | 2 | $46 |
| GENZYME CORPORATION | 1 | $33 |
| Lilly USA, LLC | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: Zoryve, TREMFYA, Bimzelx, SPEVIGO, COSENTYX, DUPIXENT, TALTZ, NEMLUVIO.
Industry payments across UT — which companies pay providers there.
